Elroselabs (Elroselabs Inc.)


Welcome to the PulseAid listing for the Elroselabs drug offered from Elroselabs Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Elroselabs Inc.
NON-PROPRIETARY NAME: Conzerol
SUBSTANCE NAME: POTASSIUM CHLORIDE; SULFUR; POTASSIUM BROMIDE; SILICON DIOXIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SODIUM CHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-12-10
END MARKETING DATE: 0000-00-00


Elroselabs HUMAN OTC DRUG Details:

Item DescriptionElroselabs from Elroselabs Inc.
LABELER NAME: Elroselabs Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 3; 6; 6; 6; 6([hp_X]/30g; [hp_X]/30g; [hp_X]/30g; [hp_C]/30g; [hp_C]/30g; [hp_X]/30g)
START MARKETING DATE: 2015-12-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70223-001_24a80a2a-7953-004d-e054-00144ff8d46c
PRODUCT NDC: 70223-001
APPLICATION NUMBER:

Other POTASSIUM CHLORIDE; SULFUR; POTASSIUM BROMIDE; SILICON DIOXIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SODIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Elroselabs Inc.Elroselabs